Země: Spojené státy
Jazyk: angličtina
Zdroj: NLM (National Library of Medicine)
ROPINIROLE HYDROCHLORIDE (UNII: D7ZD41RZI9) (ROPINIROLE - UNII:030PYR8953)
Aidarex Pharmaceuticals LLC
ROPINIROLE HYDROCHLORIDE
ROPINIROLE 0.25 mg
ORAL
PRESCRIPTION DRUG
Parkinson’s Disease Ropinirole Hydrochloride Tablets are indicated for the treatment of the signs and symptoms of idiopathic Parkinson’s disease. The effectiveness of Ropinirole Hydrochloride Tablets were demonstrated in randomized, controlled trials in patients with early Parkinson’s disease who were not receiving concomitant L-dopa therapy as well as in patients with advanced disease on concomitant L-dopa (see CLINICAL PHARMACOLOGY: Clinical Trials). Restless Legs Syndrome Ropinirole Hydrochloride Tablets are indicated for the treatment of moderate-to-severe primary Restless Legs Syndrome (RLS). Key diagnostic criteria for RLS are: an urge to move the legs usually accompanied or caused by uncomfortable and unpleasant leg sensations; symptoms begin or worsen during periods of rest or inactivity such as lying or sitting; symptoms are partially or totally relieved by movement such as walking or stretching at least as long as the activity continues; and symptoms are worse or occur only in the evening or
Tablets Each circular, biconvex, film-coated tablet contains ropinirole hydrochloride as follows: 0.25 mg: white tablets debossed with “H” on one side and “121” on other side in bottles of 100 (NDC 53217-166-30). 0.25 mg: white tablets debossed with “H” on one side and “121” on other side in bottles of 100 (NDC 53217-166-60). STORAGE: Protect from light and moisture. Close container tightly after each use. Store at controlled room temperature 20°-25°C (68°-77°F) [see USP]. Manufactured for: Heritage Pharmaceuticals Inc. Edison, NJ08837 1.866.901.DRUG (3784) Manufactured by: Alembic Limited (Formulation Division), Village Panelav, P. O. Tajpura, Near Baska, Taluka-Halol, Panchmahal, Gujarat, India. Repackaged By: Aidarex Pharmaceuticals, LLC Corona CA 92880 SINEMET is a registered trademark of Merck & Co., Inc. Revised: 04/201
Abbreviated New Drug Application
ROPINIROLE HYDROCHLORIDE- ROPINIROLE HYDROCHLORIDE TABLET, FILM COATED AIDAREX PHARMACEUTICALS LLC ---------- ROPINIROLE HYDROCHLORIDE TABLETS RX ONLY PRESCRIBING INFORMATION PATIENT INFORMATION INCLUDED DESCRIPTION Ropinirole Hydrochloride is an orally administered non-ergoline dopamine agonist. It is the hydrochloride salt of 4-[2-(dipropylamino) ethyl]-1,3-dihydro-2_H_-indol-2-one monohydrochloride and has an empirical formula of C H N O•HCl. The molecular weight is 296.84 (260.38 as the free base). The structural formula is: Ropinirole hydrochloride is a white to yellow solid with a melting range of 243° to 250°C and a solubility of 133 mg/mL in water. Each circular, biconvex, film-coated tablet contains ropinirole hydrochloride equivalent to ropinirole, 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, 4 mg, or 5 mg. Inactive ingredients consist of: croscarmellose sodium, lactose monohydrate, magnesium stearate, microcrystalline cellulose, and one or more of the following: carmine, FD&C Blue No. 2 aluminum lake, FD&C Yellow No. 6 aluminum lake, hypromellose, iron oxides (iron oxide yellow, iron oxide red and iron oxide black), polyethylene glycol, polysorbate 80 and titanium dioxide. CLINICAL PHARMACOLOGY MECHANISM OF ACTION Ropinirole Hydrochloride is a non-ergoline dopamine agonist with high relative in vitro specificity and full intrinsic activity at the D and D dopamine receptor subtypes, binding with higher affinity to D than to D or D receptor subtypes. Ropinirole has moderate in vitro affinity for opioid receptors. Ropinirole and its metabolites have negligible in vitro affinity for dopamine D , 5-HT , 5-HT , benzodiazepine, GABA, muscarinic, alpha -, alpha -, and beta-adrenoreceptors. PARKINSON’S DISEASE The precise mechanism of action of Ropinirole Hydrochloride as a treatment for Parkinson’s disease is unknown, although it is believed to be due to stimulation of postsynaptic dopamine D -type receptors within the caudate-putamen in the brain. This conclusion is supported by studies that show that 16 24 2 2 Přečtěte si celý dokument